Search

Aims: The use of extended criteria donors is a routine practice that sometimes involves extracorporeal membrane oxygenation (ECMO) in donations after cardiac death or brain death. Methods: We performed a retrospective study in a single center from January 2006 to December 2019. The study included 90 deceased donor liver transplants. The patients were divided into three groups: the donation after brain death (DBD) group (n = 58, 64.4%), the DBD with ECMO group (n = 11, 12.2%) and the donation after cardiac death (DCD) with ECMO group (n = 21, 23.3%). Results: There were no significant differences between the DBD with ECMO group and the DBD group. When comparing the DCD with ECMO group and the DBD group, there were statistically significant differences for total warm ischemia time (p < 0.001), total cold ischemia time (p = 0.023), and split liver transplantation (p < 0.001), and there was significantly poor recovery in regard to total bilirubin level (p = 0.027) for the DCD with ECMO group by repeated measures ANOVA. The 5‐year survival rates of the DBD, DBD with ECMO, and DCD with ECMO groups were 78.1%, 90.9%, and 75.6%, respectively. The survival rate was not significantly different when comparing the DBD group to either the DBD with ECMO group (p = 0.435) or the DCD with ECMO group (p = 0.310). Conclusions: Using ECMO in donations after cardiac death or brain death is a good technology, and it contributed to 35.6% of the liver graft pool. The findings of this study suggest that using ECMO in donations after cardiac death or brain death is a good technology and increase the pool of organs. Using ECMO of technology is convenient, but the material cost of machine perfusion is too expensive, especially in small organ donation centers. [ABSTRACT FROM AUTHOR]

Purpose: To investigate the long-term effects of residual bone height (RBH), maxillary sinus membrane perforation, and cavities on survival of implants with lateral maxillary sinus lifting (MSFA)., Methods: Fifty-six patients (98 implants) who underwent MSFA from 2005 to 2009 and followed up till 2019 were enrolled. RBH was assessed using a series of panoramic and periapical X-ray films. Based on the presence of RBH, sinus membrane perforation, cavities, the cumulative survival rate (CSR) were evaluated using log-rank test and risk ratio of implant failure, SPSS 21.0 software package was used to analyze the data., Results: The residual bone height of implants with sinus membrane perforation was significantly larger than those without sinus membrane perforation. The residual bone height of the survival implants was significantly larger than that of the failed implants(P<0.05), but there was no significant difference in the residual bone height between gender, smoking and cavities(P>0.05). The total CSR of 10 years after implantation by MSFA was 94.5%, of which the females was significantly higher than that of males, non-smokers was significantly higher than that of smokers, and RBH≥3 mm was significantly higher than that of RBH<3 mm(P<0.05). However, there was no significant difference in CSR between sinus membrane perforation and non-sinus membrane perforation., Conclusions: Implants with RBH<3 mm have lower CSR, and the survival is acceptable under proper oral hygiene maintenance conditions. Sinus perforation and cavity do not affect the survival of lateral MSFA implants.